DBPAP // UltiMate 3000 HPLC (MA)

The contract seeks to acquire advanced mass spectrometry and HPLC instrumentation—including the Synapt G2, MALDI ToF, LTQ XL, GC, UltiMate 3000 HPLC, and HPCL 1200 systems—to support critical research into vaccine antigens and host-pathogen interactions. These systems are essential for analyzing how post-translational modifications influence antigen structure, viral receptor binding patterns, and interactions with the host innate immune system. The research aims to uncover biochemical mechanisms that determine immune recognition and response, directly informing vaccine design and efficacy. The equipment is designated as mission-critical for the Food and Drug Administration’s Center for Biologics Evaluation and Research, and the requirement is currently unfunded. The procurement is forecasted under NAICS code 811219, with the primary point of contact being the CBER Acquisition Liaison at cberacquisitions@fda.hhs.gov, while the contracting officer role remains unspecified.